Jia-li Hu
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Pre-treatment serum apolipoprotein E: a promising prognostic indicator for nasopharyngeal carcinoma.
Journal: European journal of medical research
Published: August 22, 2025
Prognostic value of serum uric acid levels following radiotherapy and chemotherapy in nasopharyngeal carcinoma.
Journal: Molecular and clinical oncology
Published: July 09, 2025
Pre-treatment serum apolipoprotein E: a promising prognostic indicator for nasopharyngeal carcinoma.
Pre-treatment serum apolipoprotein E: a promising prognostic indicator for nasopharyngeal carcinoma.
Journal: European journal of medical research
Published: November 25, 2024
A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in Nasopharyngeal Carcinoma Based on a Risk Score Model.
Journal: Oncology research and treatment
Published: October 30, 2021
The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
Journal: Frontiers in oncology
Published: October 20, 2020
Structural and functional characterization of multiple myeloma associated cytoplasmic poly(A) polymerase FAM46C.
Journal: Cancer communications (London, England)
Published: September 07, 2020
FAM46B is a prokaryotic-like cytoplasmic poly(A) polymerase essential in human embryonic stem cells.
FAM46B is a prokaryotic-like cytoplasmic poly(A) polymerase essential in human embryonic stem cells.
Journal: Nucleic acids research
Published: July 30, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026